Correspondence to Dr Sanjib Sinha, Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India; sanjib_sinha2004{at}yahoo.co.in Background High-level ...

Dr Guila Glosser, Department of Neurology (Gates 3), University of Pennsylvania Medical Center, 3400 Spruce Street, Philadelphia, PA 19104–4283, USA email glosser{at}mail.med.upenn.edu OBJECTIVES ...

Background Creatine kinase (CK) is an enzyme found in skeletal muscles, myocardium and brain (CK–MM, CK–MB, and CK–BB isoenzymes respectively). In these tissues with high energy requirements, CK ...

Correspondence to Dr Laura McWhirter, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH8 9YL, UK; laura.mcwhirter{at}ed.ac.uk Performance validity tests (PVTs) are widely used ...

aInstitute of Clinical Neurosciences, bKanematsu Laboratories, Royal Prince Alfred Hospital, NSW, 2006 Australia Professor JD Pollard, Institute of Clinical Neurosciences, University of Sydney, ...

Correspondence to Georgios Koutsis, Neurogenetics Unit, 1st Department of Neurology, School of Medicine, Eginition Hospital, National and Kapodistrian University of Athens, Athens 11528, Greece; ...

Identifying biomarkers of Alzheimer’s disease (AD) will accelerate the understanding of its pathophysiology, facilitate screening and risk stratification, and aid in developing new therapies.

Correspondence to Dr Timothy Rittman, Department of Clinical Neurosciences, University of Cambridge, Herchel Smith Building, Forvie Site, Addenbrooke's Hospital Site, Robinson Way, Cambridge CB2 0SZ, ...

Correspondence to Dr Michael Benatar, Department of Neurology, University of Miami Miller School of Medicine, Miami, Florida, USA; MBenatar{at}med.miami.edu Notwithstanding the challenges, it is ...

2 Oxford Project to Investigate Memory and Ageing (OPTIMA), Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK Correspondence to Dr P Garrard, Stroke and ...